High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy-Reference-Cited by-同舟云学术

High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy

Published:2024-04-18 Issue:7 Volume:65 Page:1020-1023
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Tinajero Jose¹^ORCID,Ngo Dat¹,Zhang Jianying²,Tsai Ni-Chun²,Aribi Ahmed³^ORCID,Aldoss Ibrahim³,Agrawal Vaibhav³,Arslan Shukaib³^ORCID,Amanam Idoroenyi³^ORCID,Pourhassan Hoda³^ORCID,Sandhu Karamjeet³,Al-Malki Monzr³,Pullarkat Vinod³,Becker Pamela³^ORCID,Nakamura Ryotaro³^ORCID,Stein Anthony³^ORCID,Marcucci Guido³,Artz Andrew³^ORCID,Koller Paul³,Salhotra Amandeep³^ORCID

Affiliation:

1. Department of Pharmacy, City of Hope Medical Center, Duarte, CA, USA

2. Division of Biostatistics, City of Hope Medical Center, Duarte, CA, USA

3. Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2332506

Reference5 articles.

1. Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications

2. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)

3. Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial

4. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with aFLT3Mutation

5. Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytarabine/Midostaurin;Reactions Weekly;2024-08-31